{
    "_asCP": [
        "0.2-0.5 mg/kg q4-6h as needed.",
        "0.8-2.4 g tid, po, with meal",
        "1. Concomitant use of atorvastatin and cyclosporine should be avoided. 2. In patients receiving clarithromycin, itraconazole, ritonavir (plus darunavir, fosamprenavir, lopinavir, or saquinavir), atorvastatin dose exceeding 20 mg/day requires clinical assessment to ensure the lowest effect dosage is employed. 3. Rhabdomyolysis with renal dysfunction secondary to myoglobinuria has been reported. 4. Liver function test should be performed before starting statin therapy and as clinically indicated thereafter. 5. Potent CYP3A4 inhibitors such as cyclosporin, azole antifungals, macrolide antibiotics, HIV protease inhibitors, nefazodone and large quantities of grapefruit juice (> 1 quart/day) can raise the plasma level of HMG-CoA reductase inhibitors and may increase the risk of myopathy. 6. Combination of HMG-CoA reductase inhibitors and fibrates may increase the risk of myopathy. 7. Statins are contraindicated in patients with active liver disease or unexplained persistent elevations of serum transaminases. Statins are contraindicated in pregnant or lactation women. 8. The risk of myopathy appears to be increased in patients receiving higher dose of statins; in patients with multisystem diseases, e.g. renal or hepatic impairment concurrent serious infections or hypothyroidism; small body frame and frailty; and in patients undergo surgery.",
        "1. Oxcarbazepine會抑制CYP2C19的作用，與phenobarbital、phenytoin併用時，可能須減少後者的劑量。 2. Oxcarbazepine會誘導CYP3A4及CYP3A5的作用，將導致併用藥品之血中濃度降低(例如：carbamazepine、dihydropyridine類鈣離子拮抗劑及口服避孕藥)。",
        "1.EPS (extrapyramidal reactions)通常發生於剛開始服藥的時候，尤其是high-potency的品項較易出現。 2.Low-potency的品項較會有alpha antiadrenergic及 anticholinergic的作用。 3.對於老年人及糖尿病人之起始劑量應降低。",
        "1.口服劑型與含有Mg2+、AL3+之制酸劑或多價陽離子製劑(Fe2+、Zn2+)併用時，會導致吸收低下，效果減弱，請避免併用。 2.十八歲以下不建議使用。",
        "1.老年人及糖尿病人應小心使用。 2.若與酒精或其他中樞神經抑制劑合併使用會使安眠效果產生加成作用。 3.應避免用於肌無力的病人。",
        "1.藥錠排出為正常現象。 2.在老年失智病人身上會增加致命機率。 3.可能影響思考、判斷力及運動能力，故應避免操作危險機械，包括駕駛汽車。",
        "1.請勿直接倒出乾粉服用。 2.請先酌量加冷開水濕潤藥粉，接著持續加冷開水至60cc處。完成泡製後，再遵照藥袋上用法說明服用。 3.泡製後需冰箱冷藏，使用前請搖勻。 4.若對penicillin過敏的患者，使用cephalosporin類藥品應特別小心。",
        "1.請勿直接倒出乾粉服用。2.請先酌量加冷開水濕潤藥粉，接著持續加冷開水至60cc處。完成泡製後，再遵照藥袋上用法說明服用。3.泡製後需冰箱冷藏，使用前請搖勻。4.若對penicillin過敏的患者，使用cephalosporin類藥品應特別小心。",
        "1.首次打開後，於室溫 (≦25℃)可存放15天。 2.使用前將藥瓶旋轉180度，手動輕搖至少30秒，確保懸液均一性。以給藥注射器抽取適當劑量對應的體積給藥。給藥完成後須清洗注射器。",
        "10mEq/750mg/tab",
        "10mg/tab",
        "12-17 yr: 3 mg once daily, may increase by 3 mg/day increments at intervals of more than 5 days.",
        "1200mg/tab",
        "125mg/cap",
        "15-25℃乾燥儲存",
        "15-30°C儲存",
        "1500mg/pack",
        "150mg/cap",
        "15mg/tab",
        "1mg/tab",
        "1、口服劑型與含有Mg2+、AL3+之制酸劑或多價陽離子製劑(Fe2+、Zn2+)併用時，會導致吸收低下，效果減弱，請避免併用。 2、Moxifloxacin使用於<18歲族群之安全性尚未確立，動物研究觀察到Moxifloxacin 會造成未成年動物關節病變，十八歲以下不建議使用。 3、Moxifloxacin與cisapride、erythromycin、antipsychotics、tricyclic antidepressants、procainamide、quinidine、amiodarone、sotalol併用可能會延長QT間隔，故不建議併用，",
        "2.6.降血脂藥物 Drugs used for dyslipidemia 2.6.1.全民健康保降血脂藥物給付規定表 (86/1/1、87/4/1、87/7/1、91/9/1、93/9/1、97/7/1、102/8/1、108/2/1)      全民健康保險降膽固醇藥物給付規定表 非藥物治療 起始藥物治療 血脂值 血脂目標值 處方規定 1.有急性冠狀動脈症候群病史 2.曾接受心導管介入治療或外科冠動脈搭橋手術之冠狀動脈粥狀硬化患者(108/2/1) 與藥物治療可並行 LDL-C≧70 mg/dL LDL-C＜70 mg/dL 第一年應每3-6個月抽血檢查一次，第二年以後應至少每6-12個月抽血檢查一次，同時請注意副作用之產生如肝功能異常，橫紋肌溶解症。 心血管疾病 或糖尿病患者 與藥物治療可並行 TC≧160 mg/dL或 LDL-C≧100 mg/dL TC＜160 mg/dL或 LDL-C＜100 mg/dL 2個危險因子或以上 給藥前應有3-6個月非藥物治療 TC≧200 mg/dL或 LDL-C≧130 mg/dL TC＜200 mg/dL或 LDL-C＜130 mg/dL 1個危險因子 給藥前應有3-6個月非藥物治療 TC≧240 mg/dL或 LDL-C≧160 mg/dL TC＜240 mg/dL或 LDL-C＜160 mg/dL 0個危險因子 給藥前應有3-6個月非藥物治療 LDL-C≧190 mg/dL LDL-C＜190 mg/dL 全民健康保險降三酸甘油酯藥物給付規定表 非藥物治療 起始藥物治療 血脂值 血脂目標值 處方規定 心血管疾病 或糖尿病病人 與藥物治療可並行 TG≧200 mg/dL且(TC/HDL-C > 5 或HDL-C < 40 mg/dL) TG＜200 mg/dL 第一年應每3-6個月抽血檢查一次，第二年以後應至少每6-12個月抽血檢查一次，同時請注意副作用之產生如肝功能異常，橫紋肌溶解症。 無心血管疾病病人 給藥前應有3-6個月非藥物治療 TG≧200 mg/dL且(TC/HDL-C > 5 或HDL-C < 40 mg/dL) TG＜200 mg/dL 無心血管疾病病人 與藥物治療可並行 TG≧500 mg/dL TG＜500 mg/dL ★心血管疾病定義： (一) 冠狀動脈粥狀硬化病人患者包含：心絞痛病人，有心導管證實或缺氧性心電圖變化或負荷性試驗陽性反應者(附檢查報告) (二) 缺血型腦血管疾病病人包含： 1.腦梗塞。 2.暫時性腦缺血患者(TIA)。（診斷須由神經科醫師確立） 3.有症狀之頸動脈狹窄。（診斷須由神經科醫師確立）  ★危險因子定義： 1.高血壓 2.男性≧45歲，女性≧55歲或停經者 3.有早發性冠心病家族史(男性≦55歲，女性≦65歲) 4.HDL-C < 40 mg/dL 5.吸菸(因吸菸而符合起步治療準則之個案，若未戒菸而要求藥物治 療，應以自費治療)。 紅字部分自108年2月1日起實施",
        "20mEq/15mL/amp",
        "20mL/amp",
        "20mg/mL, 60mL/btl",
        "20mg/ml/amp",
        "225-450 mg bid.",
        "225mg/tab",
        "25-50 mg/kg/day in 4 divided doses; dosage may be doubled for severe infections.",
        "250-500 mg q12h; for severe infection, 750 mg q12h.",
        "250mg/Tab",
        "250mg/tab",
        "25mg/mL, 60mL/btl",
        "25°C以下儲存",
        "25℃以下",
        "25℃以下儲存",
        "2mg/mL 60mL/btl",
        "2mg/tab",
        "3-12 mg once daily, administered in the morning. Dose above 6 mg/day should be made only after clinical reassessment and should occur at intervals of more than 5 days. When dose increases are indicated, small increments of 3 mg/day are recommended. Max. 12 mg/day.",
        "3mg/tab",
        "400 mg PO QD",
        "400mg/tab",
        "5-30 mg q4h as needed.",
        "50/12.5 mg/mL, 60mL/btl",
        "5mg/mL, 300mL/btl",
        "5mg/tab",
        "60mg/mL, 100mL/btl",
        "60mg/tab",
        "7.5mg/tab",
        "75mg/tab",
        "800mg/pack",
        "AB37196100",
        "AB58253100",
        "AC01963100",
        "AC17280151",
        "AC261541G0",
        "AC285921G0",
        "AC31505100",
        "AC32286100",
        "AC369441G0",
        "AC43152151",
        "AC44248100",
        "AC45671100",
        "AC466811G0",
        "AC49018100",
        "AC49146100",
        "AC49758151",
        "AC58956135",
        "AC60259100",
        "AC60316100",
        "AC60560100",
        "Adult: 125-250 mg q12h; doubled in severe infections Gonorrhoea, 1 g as a single dose.",
        "Alfasigma S.P.A.",
        "Aminophylline",
        "Aminophylline 225 mg",
        "Aminophylline SR 緩釋_口服 225mg/tab (Antiasth)",
        "Amoxicillin 50 mg/mL",
        "Amoxicillin/Clavulanic acid",
        "Amyotrophic lateral sclerosis (ALS): 50 mg (=10mL) q12h, 1 hr before or 2 hr after a meal. No increased benefit can be expected from higher daily doses, but adverse events are increased.",
        "Anpo",
        "Antianginal: 150-225 mg in divided dose. Antiplatelet: 300-450 mg in divided dose. Max. 800 mg/day.",
        "Antiasth",
        "Anticholinergic的藥品應慢慢增、減劑量以達最好療效。",
        "Antipsychotic: Child 3-12 yr, 0.05-0.15 mg/kg/day in 2-3 divided doses. Tourette's syndrome: PO Child 3-12 yr: 0.05-0.075 mg/kg/day.",
        "Antipsychotic: PO: Initially, 6-15 mg/day; maintenance, 15-20 mg/day. Elderly or debilitated patients, Initially, 0.5-1.5 mg; maintenance 2-8 mg/day. Mental retardation with hyperactivity: PO: initially, 80-120 mg/day, gradually reduced to a maintenance dose of 60 mg/day. Tourette's syndrome: PO Adult: Initially, 6-15 mg/day in divided doses; maintenance, 9 mg/day.",
        "Atorvastatin Calcium",
        "Avelox",
        "BC17577100",
        "BC21676100",
        "BC22931116",
        "BC23223100",
        "BC23538123",
        "BC28266166",
        "Bayer Healthcare Manufacturing S.r.l.(拜耳)",
        "Biperiden",
        "Biperiden 2 mg",
        "Biperiden 口服 2mg/tab (Bipiden)",
        "Bipiden",
        "Budema",
        "Bumetanide",
        "Bumetanide 1 mg",
        "Bumetanide 口服 1mg/tab (Budema)",
        "C. difficile infection; treatment: Infants, Children, and Adolescents: Oral: 40 mg/kg/day Q6-8H for 7-10 days; maximum daily dose: 2,000 mg/day.",
        "Caffeine",
        "Caffeine 20mg/ml/amp (Peyona)",
        "Caffeine Citrate 20 mg/mL",
        "Candidiasis: PO: UTI 200~400 mg qd Esophageal: 400 mg (or 6 mg/kg) on day 1, then 200~400 mg (3~6 mg/kg) qd Oropharyngeal: 200 mg on day 1, then 100~200 mg IVD qd Candidemia: 800 mg (or 12 mg/kg) on day 1, then 400 mg (6 mg/kg) qd Cryptococcal meningitis: PO Induction: 800~1200 mg qd for ≥ 2 wks Consolidation: 800 mg qd for ≥ 8 wks Maintenance: 800 mg qd for ≥ 8 months",
        "Ceflour",
        "Cefuroxime",
        "Cefuroxime 250 mg",
        "Cefuroxime 口服 250mg/tab (Ceflour)",
        "Center(晟德)",
        "Cephalexin",
        "Cephalexin 25 mg/mL",
        "Cephalexin oral susp 液劑 25mg/mL, 60mL/btl (Ulexin)",
        "Chengda Pharmaceutical Co., Ltd(成大藥品)",
        "Children 10-17 y/o: 20 mg/day",
        "China Chemical & Pharmaceutical Co., Ltd. (CCPC)(中國化學製藥)",
        "Chlid ≧ 3 mo: 125 mg q12h. For otitis media: < 2 yr, 125 mg q12h; ≧ 2 yr: 250 mg q12h.",
        "Ciprofloxacin",
        "Ciprofloxacin 250 mg",
        "Ciprofloxacin 口服 250mg/tab (Ciprogen)",
        "Ciprogen",
        "Clavulanate 12.5 mg/mL",
        "Clostridioides difficile infection, treatment: Initial or recurrent, nonfulminant infection: Oral: 125 mg Q6H for 10 days. Fulminant infection: Oral: 500 mg Q6H for 10 days.",
        "Const-K ER",
        "Coxine",
        "Curam",
        "Curam oral susp 液劑 50/12.5 mg/mL, 60mL/btl (Amoxicillin/ Clavulanic acid)",
        "Curam syrup之Amoxicillin/Clavulanate比例為4：1，和Augmentin syrup比例不同(7：1)，劑量上會有些許差異，請注意。",
        "Delpharm Huningue S.A.S(Delpharm Huningue S.A.S)",
        "Diflucan",
        "Dipyridamole",
        "Dipyridamole 75 mg",
        "Dipyridamole 口服 75mg/tab (Parotin)",
        "Dormicum",
        "Fareva Amboise(Fareva Amboise)",
        "Fluconazole",
        "Fluconazole 150 mg",
        "Fluconazole cap 高_口服 150mg/cap (Diflucan)",
        "Folina",
        "For relieve the pain of degenerative arthritis: 1 pack QD.",
        "Fuliclin",
        "General dosing: PO: 1 month~17 y/o: 6~12 mg/kg/dose, followed by 3~12 mg/kg/dose qd (Duration and dosage depends on severity; Max 800 mg/dose)",
        "Genzyme Ireland Ltd(Genzyme)",
        "Glucosamine sulfate",
        "Glucosamine sulfate 1500 mg",
        "Glucosamine sulfate powder 1500mg/pack (Viartril-S powder for oral solution)",
        "Halin",
        "Haloperidol",
        "Haloperidol 5 mg",
        "Haloperidol 口服 5mg/tab (Halin)",
        "Hui Chun Tang(回春堂)",
        "Ibuprofen",
        "Ibuprofen 20 mg/mL",
        "Ibuprofen oral susp 液劑 20mg/mL, 60mL/btl (Ibuprofen)",
        "ImageImageImage",
        "Impax Laboratories (Taiwan), Inc. for Bora Pharmaceutical(保瑞藥業委託益邦製藥)",
        "Infection due to anaerobic bacteria: 7.5 mg/kg Q6H (usually 500 mg Q6H, Max:4 g/day) for 7-10 days, or longer as clinically indicated C. difficile diarrhea(Nonsevere): 500 mg tid for 10-14 days Bacterial vaginosis: 500 mg bid for 7 days  Infection due to protozoan infections: Amebic dysentery(acute): 750 mg tid for 5-10 days Amebic liver abscess: 500-750 mg tid for 5-10 days Trichomoniasis: 2g as a single dose or 500 mg bid for 7 days Giardiasis: 250 mg tid for 5 days",
        "Initially, 10 mg 30 min before IVD is discontinued, then 10 mg q2h for 24 hr; maintenance, 10-20 mg q4-6h.",
        "Initially, 600 mg/day in 2 divided dose, up to 2,400 mg/day.",
        "Initially, 8-10 mg/kg/day in 2 divided dose. Max. 60 mg/kg/day.",
        "Isosorbide Mononitrate",
        "Isosorbide Mononitrate 60 mg",
        "Isosorbide Mononitrate CR 口服 60mg/tab (Coxine)",
        "Italfarmaco, S.A.",
        "K-Glu",
        "LIP4FD35",
        "Leucovorin",
        "Leucovorin 15 mg",
        "Leucovorin 別名: Folinic Acid, Folinate",
        "Leucovorin 口服 15mg/tab (Folina)",
        "Lipitor Film-Coated Tablet 20 mg atorvastatin/tab",
        "Loading dose: IV: 20 mg/kg caffeine citrate as a one-time dose Maintenance dose: Oral, IV: 5 mg/kg/dose caffeine citrate once daily, beginning 24 hours after loading dose",
        "Meloxicam",
        "Meloxicam 15 mg",
        "Meloxicam 口服 15mg/tab (Mopik)",
        "Metronidazole",
        "Metronidazole 250 mg",
        "Metronidazole tab 口服 250mg/Tab (Fuliclin)",
        "Midazolam",
        "Midazolam 7.5 mg",
        "Midazolam 口服 7.5mg/tab (Dormicum)",
        "Mopik",
        "Morphine Sulfate",
        "Morphine Sulfate 2 mg/mL",
        "Morphine Sulfate Oral Solution",
        "Morphine Sulfate Oral Solution 液劑 2mg/mL 60mL/btl",
        "Moxifloxacin",
        "Moxifloxacin 400 mg",
        "Moxifloxacin 口服 400mg/tab (Avelox)",
        "Nang Kuang(南光)",
        "Orient PHARMA(友霖生技)",
        "Overdosage of folic acid antagonists: IVD, up to 75 mg within 12 hr, followed by 12 mg IM q6h for 4 doses. Leucovorin rescue: Begin within 24 hr of methotrexate administration. Doses of up to 120 mg > 12-24 hr by IM or IVD, followed by IM 12-15 mg or PO 15 mg q6h for next 48 hr with low doses of methotrexate, PO 15 mg q6h. Megaloblastic anaemia: IM, PO, not more than 1 mg/day.",
        "Oxcarbazepine",
        "Oxcarbazepine 60 mg/mL",
        "Oxcarbazepine oral susp 60mg/mL, 100mL/btl (Trileptal)",
        "PFIZER PHARMACEUTICALS LLC (Puerto Rico)(2013.10.16) PFIZER IRELAND PHARMACEUTICALS (Ireland)(old)",
        "PO, initially, 1-2 mg tid, maintenance 2-12 mg/day in divided doses. Max. 16 mg/day. Drug-induced extrapyramidal reactions: PO, 2 mg 1-3 times/d",
        "PO. 15mL tid-qid.",
        "PO. Adults, initially, 10-20 mg qd; maintenance, 10-80 mg qd. Children 10-17 y/o, initially, 10 mg qd, may increase to max. 20 mg/day.",
        "PO: 7.5-15 mg. In premedication, 15 mg given 30-60 min before the operation.",
        "PO: Taken with food. Antibacterial in anaerobic infection: 7.5 mg/kg q6h for 7-10 days or longer. Max. 4 g/day. Antiprotozoal: Amebiasis & Balantidiasis: Child: 35-50 mg/kg/day in 3 divided doses for 10 days. Giardiasis:Child: 5 mg/kg tid for",
        "Paliperidone",
        "Paliperidone 3 mg",
        "Paliperidone ER 口服 3mg/tab (Pardone)",
        "Pardone",
        "Parotin",
        "Peyona",
        "Phosphate 0.97 mmol/mL",
        "Phosphate Oral Solution",
        "Piracetam",
        "Piracetam 1200 mg",
        "Piracetam 口服 1200mg/tab (Syntam)",
        "Potassium Chloride",
        "Potassium Chloride 10 mEq",
        "Potassium Chloride ER 口服 10mEq/750mg/tab (Const-K ER)",
        "Potassium Gluconate",
        "Potassium Gluconate 312 mg/mL",
        "Potassium Gluconate oral sol 口服液 20mEq/15mL/amp (K-Glu)",
        "Prevention of hypokalemia: 20 to 40 mEq/day in 1 to 2 divided doses. Treatment of hypokalemia: Mild to moderate: 40 to 100 mEq daily in divided doses Severe hypokalemia: 40 mEq po tid to qid",
        "Psycho-organic syndromes: 4.8 g/day, then reducing to 2.4 g/day. Cerebro-vascular accidents: Acute stage: 9-12 g/day. Subacute & chronic stages: 4.8-6 g/day. Myoclonus of cortical origin: 7.2 g/day, increasing by 4.8 g/day every 3 or 4 days up to a max. 24 g/day.",
        "Recipharm Leganes S.L.U.(Recipharm)",
        "Renvela",
        "Riluzole",
        "Riluzole 5 mg/mL",
        "Riluzole oral susp 5mg/mL, 300mL/btl (Teglutik)",
        "Ritodrine",
        "Ritodrine 10 mg",
        "Ritodrine 口服 10mg/tab (Anpo)",
        "RottaPharma(RottaPharma)",
        "Safety and effectiveness of potassium chloride extended-release tablets in children have not been established.",
        "Safety and efficacy not established in pediatrics.",
        "Safety and efficacy of oral and IV moxifloxacin have not been established in pediatric patients",
        "Sandoz GmbH(山德士)",
        "Sevelamer Carbonate",
        "Sevelamer Carbonate 800 mg",
        "Sevelamer Carbonate powder 800mg/pack (Renvela)",
        "Sodium Phosphate",
        "Sodium Phosphate oral sol 專案 20mL/amp (Phosphate Oral Solution)",
        "Swiss Pharm for U-Liang(優良委託瑞士藥廠)",
        "Swiss Pharm(瑞士藥廠)",
        "Synmosa(健喬信元)",
        "Syntam",
        "TTY Biopharm(東洋)",
        "Taiwan Biotech(信東)",
        "Teglutik",
        "Treatment of dyslexia in combination with logopedics in children from 8-13 yr: 3.2 g/day.",
        "Trileptal",
        "U-Liang For Synmosa(健喬信元委託優良)",
        "UBI Pharma Inc. for PPCD(管製藥品廠委託聯亞藥業)",
        "Ulexin",
        "Usual dose: 10 ml PO tid",
        "Usual dose: Infants ≥3 months, Children, Adolescents <40 kg: amoxicillin 20 to 40 mg/kg/day divided into 3 doses; Max: amoxicillin 90 mg/kg/day",
        "Vancomycin 125 mg",
        "Vancomycin_口服",
        "Vancomycin_口服 cap 125mg/cap (Vancover)",
        "Vancover",
        "Viartril-S powder for oral solution",
        "X000224138",
        "X; 懷孕分級說明",
        "York pharmaceutical CO., LTD.(約克製藥)",
        "Yung Shin(永信)",
        "Yusheng Pharmaceutical Co.Ltd(優生)",
        "[0010] Narcotics",
        "[0020] Non-narcotic Analgesics and Antipyretics",
        "[0030] Antiinflammatory and anti-rheumatics: NSAIDs",
        "[0031] Other antiinflammatory and antirheumatic agents, non-steroids",
        "[0910] Nitrates",
        "[0950] Antiplatelets Agents",
        "[1510] Penicillins",
        "[1521] First Generation Cephalosporins",
        "[1522] Second Generation Cephalosporins",
        "[1570] Drugs Used in Anaerobic Infection",
        "[1580] Quinolones",
        "[1592] Glycopeptides",
        "[1890] Miscellaneous Specific Antidotes",
        "[2130] Imidazoles and Triazoles",
        "[2410] Diuretics",
        "[6610] Replenishers and Regulators of Water and Electrolytes",
        "[6910] Anticonvulsants",
        "[6932] Nootropic Agents",
        "[6951] Centrally Active Anticholinergic Drugs",
        "[6990] Neurologic Miscellaneous Agents",
        "[7511] Benzodiazepines",
        "[7551] Typical antipsychotics",
        "[7553] Atypical antipsychotics",
        "[7811] Xanthine derivatives",
        "[8420] Uterine Relaxants",
        "[請勿直接倒出乾粉服用!!] 使用前需泡製，泡法：先加少量冷開水濕潤藥粉，接著持續加水至充填線(瓶身環狀凹陷處)。服藥前請先搖勻。製備好的懸浮劑必須冷藏(攝氏2-8度)並在7日內用完。",
        "usual 12-20mg/kg/day, ≥ 8years 0.5-1 tablet/ time chronic asthma increment of 25-42mg/kg/day",
        "不可將藥錠嚼碎， 剝半或磨粉；藥錠若排出體外為正常現象；可能影響思考、判斷力及運動能力，避免操作機械或駕車",
        "丘疹、腹瀉、過敏反應、嘔吐、噁心、蕁麻疹",
        "以足量水服用；若發生喉痛、口腔/黏膜潰瘍、皮疹等症狀，宜停藥並立即就醫",
        "佩里波持續性藥效錠(7/片)",
        "使用前將藥瓶旋轉180度，手動輕搖至少30秒，確保懸液均一性。以給藥注射器抽取適當劑量對應的體積給藥。給藥完成後須清洗注射器。",
        "使用前須搖勻; 用藥後若發生喉痛、口腔/黏膜潰瘍、皮疹等症狀，應考慮可能為藥品不良反應，宜立即就醫並考慮停藥",
        "依普芬口服懸液劑",
        "便秘、消化不良、脹氣、腹痛、腹瀉、嘔吐、噁心",
        "便秘、胃痛、脹氣、腹瀉、過敏反應、嘔吐、噁心",
        "優力黴素口服懸液用顆粒",
        "冠欣持續性藥效膜衣錠",
        "凡可復膠囊",
        "利尿",
        "十八歲以下不建議使用(高抗藥性菌種或特定感染除外)。 Usual dosage range for 1-17 y/r(Red Book [AAP 2015]): Mild to moderate infections: 10 mg/kg/dose PO Q12H (max: 500 mg/dose) Severe infections: 15 to 20 mg/kg/dose PO Q12H (max: 750 mg/dose)",
        "協助放鬆情緒",
        "口乾、口腔周圍感覺異常、肝功能異常、疼痛、虛弱、暈眩、嘔吐、噁心、頭痛",
        "口乾、失眠、皮疹、便秘、姿態性低血壓、視力模糊、嗜睡、體重增加",
        "口咽發炎、皮疹、腹瀉",
        "口服",
        "口鼻乾燥、便秘、畏光、倦怠、排尿困難、視力模糊、嗜睡、暈眩、嘔吐、噁心",
        "可剝半，但不宜磨粉或嚼碎",
        "可能引起尿液變色；可能出現味覺改變(金屬味覺)；服藥期間勿飲酒。",
        "可能造成頭暈，避免操作機械或駕車",
        "可降低膽固醇、三酸甘油酯、低密度脂蛋白、極低密度脂蛋白, 減少中風及冠狀動脈疾病之發生率. (980602)",
        "可靜脈注射或口服給予",
        "含磷口服液",
        "味覺差，不宜磨粉；請按時服藥至療程結束",
        "哈寧錠",
        "啡那輸注溶液及口服液",
        "喘悅長效錠(6/片)",
        "喜博欣",
        "喜華膜衣錠",
        "單次口服投與K+ > 40 mEq通常會造成無法耐受的腸胃不適，一般建議單次劑量不要超過25 mEq/dose以減輕腸胃道副作用。",
        "失眠、皮疹、光敏感、暈眩、腹痛、腹瀉、噁心、頭痛",
        "失眠、皮疹、光敏感、陰道有分泌物及疼痛、虛弱、暈眩、腹痛、腹瀉、噁心、頭痛",
        "失眠、肌張力改變、姿態性低血壓、唾液過多、錐體外路症狀(如手抖四肢僵硬等)",
        "奧地利",
        "威洛速膜衣錠 (5/片)",
        "婦力清錠",
        "安寶錠",
        "安胎",
        "室溫",
        "室溫 (≦25℃)",
        "室溫 (≦25℃)；避光存放",
        "室溫 (≦25℃)；首次打開後，可存放15天。",
        "室溫 (≦30℃)",
        "室溫(25°C)；避光儲存",
        "室溫(< 25°C)",
        "室溫(< 30°C)",
        "室溫(≦25℃)；避光存放",
        "室溫20-25℃",
        "室溫儲存",
        "導美睡錠",
        "小於 25°C乾燥儲存",
        "小於 25°C儲存",
        "小於 30°C儲存",
        "小於 30°C儲存；開封後可保存7週。",
        "小於 30℃儲存",
        "尿液紅棕色、金屬味、腹瀉、噁心、頭痛",
        "幻覺、倦怠、健忘、嗜睡、憂鬱、頭痛",
        "康是鉀持續性藥效錠",
        "心搏過速,低血壓、暈眩、腹瀉、嘔吐、潮紅、噁心、頭痛",
        "心搏過速、低血壓、暈眩、噁心、頭痛",
        "心搏過速、失眠、發抖、煩躁不安、嘔吐、噁心、頭痛",
        "心搏過速、皮疹、低血壓,尿滯留、便秘、腹瀉、嘔吐、噁心",
        "心搏過速、血糖異常、靜脈炎",
        "心臟節律異常、胃不適、發抖、視覺障礙、嘔吐、噁心、頭痛",
        "心臟衰竭,狹心症",
        "情緒穩定劑",
        "愛爾蘭",
        "把整包粉劑加在30 mL的水中，用力攪拌並在30分鐘內全部喝完(本品不會溶解)",
        "抗帕金森氏症",
        "抗生素",
        "抗黴菌",
        "支氣管擴張",
        "改善腦代謝功能",
        "改善葉酸拮抗劑所引起毒性",
        "整粒吞服，勿咬碎",
        "整顆吞服。與食物併服可減緩腸胃不適副作用。若解黑便請盡快就醫。藥粒可能隨糞便完整排出是正常現象。",
        "新品 K-Glu 含 K 1.3 mEq/mL，舊品KCL solusion含 K 0.67 mEq/mL。新品為舊品濃度兩倍。(開封後效期請見附加檔案)",
        "早產兒呼吸暫停",
        "普利腫錠",
        "暉致醫藥股份有限公司",
        "未泡製前室溫儲存；配製後冰箱中(冷藏)可存放 7天",
        "本藥未開封可儲存於室溫(< 30°C)。泡製後需冷藏，可存放7天。",
        "欣坦膜衣錠",
        "止吐,情緒穩定劑",
        "止痛",
        "每 mL 含有 20mg caffeine citrate (相當於 caffeine 10mg)",
        "水腫、胃痛、暈眩、腹痛、腹瀉、過敏、嘔吐、噁心、頭痛",
        "水腫、胃痛、胃腸道潰瘍、暈眩、腹瀉、過敏、嘔吐、噁心、頭痛",
        "法國",
        "泰復肯膠囊 (4/片)",
        "消炎止痛",
        "溶於⼀杯⽔(約100 mL)，與餐併服較佳。",
        "溶於一杯水(約100 mL)，與餐併服較佳。",
        "特魯希口服懸浮液",
        "用於管灌病人時，請直接敲碎膠囊後再溶於至少10 mL飲用水後於1小時內服用。",
        "癲癇",
        "百比停錠",
        "皮疹,胃腸不適、黃疸、搔癢、腹脹、腹瀉、噁心",
        "皮疹、肝功能異常、胃腸不適、暈眩、腹瀉、嘔吐、噁心、蕁麻疹",
        "皮膚炎、暈眩、腹痛、嘔吐、噁心、頭痛",
        "皮膚過敏、倦怠、焦慮、發抖、嗜睡、暈眩、運動失調、嘔吐、複視、噁心、頭痛",
        "硫酸嗎啡口服液",
        "磷減樂口服懸液用粉劑",
        "立普妥膜衣錠",
        "紅斑、發冷或發熱、噁心、蕁麻疹",
        "維諾心膜衣錠",
        "維骨力加強型口服溶液用粉劑",
        "緩解退化性關節炎疼痛",
        "義大利",
        "肌萎縮脊髓側索硬化症",
        "胃痙攣、嘔吐、噁心",
        "胃腸不適、暈眩、過敏、嘔吐、噁心",
        "胃腸脹氣、腹痛、腹瀉、嘔吐、噁心",
        "脹氣、腹痛、腹瀉、嘔吐、噁心",
        "腹瀉、嘔吐、噁心、頻尿",
        "膜衣錠",
        "自批號HH1255起，採用新防偽標籤。   公告日期： 2024/02/05",
        "臺灣",
        "與制酸劑至少錯開兩小時；請勿與乳製品同時服用。",
        "與鐵劑,制酸劑至少錯開兩小時服用",
        "芙琳亞錠15毫克",
        "若對penicillin過敏的患者，使用cephalosporin類藥品應特別小心。",
        "莫比克錠 15 毫克",
        "衛署藥製字第001963號",
        "衛署藥製字第017280號",
        "衛署藥製字第026154號",
        "衛署藥製字第028592號",
        "衛署藥製字第031505號",
        "衛署藥製字第032286號",
        "衛署藥製字第036944號",
        "衛署藥製字第037196號",
        "衛署藥製字第043152號",
        "衛署藥製字第044248號",
        "衛署藥製字第045671號",
        "衛署藥製字第046681號",
        "衛署藥製字第049018號",
        "衛署藥製字第049146號",
        "衛署藥製字第049758號",
        "衛署藥輸字第017577號",
        "衛署藥輸字第021676號",
        "衛署藥輸字第022931號",
        "衛署藥輸字第023223號",
        "衛署藥輸字第023538號",
        "衛署藥輸字第023724號",
        "衛署藥輸字第025733號",
        "衛部藥製字第058253號",
        "衛部藥製字第058956號",
        "衛部藥製字第060259號",
        "衛部藥製字第060316號",
        "衛部藥製字第060560號",
        "衛部藥輸字第027090號",
        "衛部藥輸字第028266號",
        "補充磷酸鹽",
        "補充鉀離子",
        "西班牙",
        "解熱消炎止痛",
        "諾快寧口服懸液用粉劑",
        "避免操作機械或駕車",
        "鉀補口服液",
        "除癲達口服懸浮液",
        "靜脈滴注",
        "預防血液凝集",
        "頭痛、腹痛、便秘或腹瀉、肝功能異常、肌肉痛等, 其他副作用無法詳載, 若有不適, 請洽醫師或藥師",
        "飯前服用",
        "高磷酸鹽血症,磷結合劑",
        "高膽固醇血症、高三酸甘油脂血症。對於臨床上沒有冠心病的第二型糖尿病患者，但是至少有任一其他冠心病危險因子，包括高血壓、視網膜病變、白蛋白尿、或吸煙，Lipitor適用於：降低心肌梗塞的風險、降低中風的風險。降低冠心病高危險群的心血管事件發生率對於臨床上沒有冠心病的高血壓患者，但是至少有三個其他冠心病危險因子，包括第二型糖尿病、年紀大於等於55歲、微白蛋白尿或蛋白尿、吸煙、或第一等親在55歲(男性)或60歲(女性)前曾經發生冠心病事件，Lipitor適用於：降低心肌梗塞的風險、降低中風的風險、降低血管再造術與心絞痛的風險。"
    ],
    "_asNoun": [
        "字號",
        "學名"
    ],
    "哈寧錠": [
        "哈寧"
    ],
    "喜博欣": [],
    "安寶錠": [
        "安寶"
    ],
    "婦力清錠": [
        "婦力清"
    ],
    "導美睡錠": [
        "導美睡"
    ],
    "普利腫錠": [
        "普利腫"
    ],
    "百比停錠": [
        "百比停"
    ],
    "凡可復膠囊": [
        "凡可復"
    ],
    "含磷口服液": [
        "含磷"
    ],
    "喜華膜衣錠": [
        "喜華",
        "喜華膜衣"
    ],
    "欣坦膜衣錠": [
        "欣坦",
        "欣坦膜衣"
    ],
    "鉀補口服液": [
        "鉀補"
    ],
    "立普妥膜衣錠": [
        "立普妥",
        "立普妥膜衣"
    ],
    "維諾心膜衣錠": [
        "維諾心",
        "維諾心膜衣"
    ],
    "芙琳亞錠15毫克": [
        "芙琳亞"
    ],
    "硫酸嗎啡口服液": [
        "硫酸嗎啡"
    ],
    "喘悅長效錠(6/片)": [
        "喘悅",
        "喘悅長效",
        "喘悅長效錠"
    ],
    "莫比克錠 15 毫克": [
        "莫比克"
    ],
    "泰復肯膠囊 (4/片)": [
        "泰復肯",
        "泰復肯膠囊 "
    ],
    "依普芬口服懸液劑": [
        "依普芬"
    ],
    "特魯希口服懸浮液": [
        "特魯希"
    ],
    "除癲達口服懸浮液": [
        "除癲達"
    ],
    "威洛速膜衣錠 (5/片)": [
        "威洛速",
        "威洛速膜衣",
        "威洛速膜衣錠 "
    ],
    "康是鉀持續性藥效錠": [
        "康是鉀",
        "康是鉀持續性藥效"
    ],
    "冠欣持續性藥效膜衣錠": [
        "冠欣",
        "冠欣持續性藥效",
        "冠欣持續性藥效膜衣"
    ],
    "啡那輸注溶液及口服液": [
        "啡那",
        "啡那輸注溶液及"
    ],
    "磷減樂口服懸液用粉劑": [
        "磷減樂"
    ],
    "諾快寧口服懸液用粉劑": [
        "諾快寧"
    ],
    "優力黴素口服懸液用顆粒": [
        "優力黴素"
    ],
    "佩里波持續性藥效錠(7/片)": [
        "佩里波",
        "佩里波持續性藥效",
        "佩里波持續性藥效錠"
    ],
    "維骨力加強型口服溶液用粉劑": [
        "維骨力"
    ]
}